Hide Board Information

Show Board Information

Tourmaline Bio, Inc. TRML

Board Mod: Add me as mod

Asst Mods:

Last Post: 04/02/2024 6:02:11 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Tourmaline Bio, Inc. (NASDAQ: TRML) Stock Message Board

1. TRML Company Profile

    

2. TRML Time & Sales

    

3. TRML Recent News

    

4. TRML Filings

    

5. TRML Financials

    

6. TRML Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Tourmaline Bio, Inc. TRML

Recent Articles

• Psyence BioMed Achieves Milestone in Ibogaine Extraction Process
• Innovations in Alzheimer’s Treatment: Anavex Life Sciences Shines
• First American Uranium Inc. Announces Share Consolidation Plans
• DT Midstream Sees Impressive Financial Growth in Q2 2025
• Edible Garden's Organic Hydroponic Basil: A Revolutionary Launch
• ZenaTech Elevates Drone Strategy Through AUVSI Membership Boost
• Hillman Solutions Unveils Robust Corporate Responsibility Initiatives
• Plus Therapeutics Enhances CNSide Diagnostic for Cancer Care
• Intellia Therapeutics Set to Discuss Q2 2025 Earnings Insights
• Kura Oncology's Upcoming Q2 2025 Financial Results Report
• Global Crossing Airlines: Upcoming Q2 Conference Call Details
• MariMed Expands Distribution of Medical Cannabis Products
• Flow Capital's Strategic Investment Fuels Common Wealth's Growth
• BriaCell Makes Progress with UCLA Health in Phase 3 Study
• Commerce.com Reports Strong Second Quarter Performance
• FOXO Technologies Expands Operations with License Renewal
• Alliant Credit Union Records Unprecedented Growth in Mortgages
• Key Insights and Speaker Highlights from the Asia Go IPO Summit
• Wayfair Expands Retail Presence with New Store in Denver
• Orrön Energy Sells 76 MW Solar Project, Expanding Green Portfolio
• Real Matters Delivers Strong Q3 Results Amid Market Changes
• International Paper's Latest Earnings Reveal Strategic Growth Plans
• CSW Industrials Breaks Records in First Quarter Financials
• XPO Logistics Reveals Strong Financial Performance in Q2
• Innovative Research Insights from the Alzheimer's Conference
• Gildan's Remarkable Revenue Growth and Adjusted EPS Performance
• Enlil Forms Partnerships to Transform MedTech and FDA Success
• ATCO Ltd. Reports Strong Q2 2025 Earnings with Growth
• Future of Finance: CFOs Embrace Cryptocurrency Strategies
• AMETEK Reflects Growth with Record Q2 Earnings Announcement
• Howmet Aerospace's Exciting Second Quarter 2025 Performance
• Quanta Services' Impressive Q2 2025 Earnings Insights
• Unveiling the 2025 Outlander Trail Edition: Adventure Awaits
• Transforming Transplantation: Buckeye and Afflo's Game-Changer
• Stagwell Inc. Sees Solid Revenue Growth in Latest Earnings
• S&P Global's Strong Second Quarter Financial Performance Revealed
• Bill Eager to Lead S&P Global Mobility as New President
• GreenHill Investment Reporting's Commitment to Excellence Shines
• Sound Blade Medical Names Neil Barman as New CEO
• Kimco Realty Reports Strong Q2 2025 Results with Increased Guidance
• CMG Expands Its Software Solutions with SeisWare Purchase
• Relmada Therapeutics Announces Q2 2025 Financial Results Call
• PyroGenesis Secures Major Titanium Powder Order from Europe
• Mastech Digital to Present Q2 Financial Outcomes Soon
• Lightspeed Commerce Reveals Impressive Q1 2026 Financials
• ISC Successfully Extends Credit Facility Until 2029
• BTCS Engages in Key Fireside Chat Discussion with Analysts
• Xanadu Mines Moves Toward Voluntary TSX Delisting Process
• Daisy Enhances Presence with Strategic Acquisition in Boston
• Medicenna Grants Five New Patents for IL-2 and IL-4 Innovations